scholarly journals Public intent profile towards medical facility visualisation systems in russian federation: a one-stage sociological survey

2021 ◽  
Vol 28 (6) ◽  
pp. 59-72
Author(s):  
A. A. Kurmangulov ◽  
Yu. S. Reshetnikova
Keyword(s):  
Russian Federation ◽  
Medical Facility ◽  
One Stage

scholarly journals New way of closure of upper jaw defects

2021 ◽  
Vol 11 (3) ◽  
pp. 30-35
Author(s):  
I. A. Zaderenko ◽  
M.  T. Berdigylyjov ◽  
I. V. Orlova ◽  
A. M. Segura ◽  
A. O. Sekretnaya ◽  
...  
Keyword(s):  
Blood Supply ◽  
Russian Federation ◽  
One Stage ◽  
Results Of Treatment ◽  
Aesthetic Results ◽  
The Russian Federation ◽  
Upper Jaw ◽  
Jaw Defects

Article describes new original way of one-stage closure of upper jaw defects by using cutaneous-adiposal flap. The method is patented (patent of the Russian Federation for invention No. 2489096). We propose to use cutaneous-adiposal flap, mobilized in nasolabial furrow area, with axial pattern blood supply from angular artery and vein, by rotating to defect through buccal tonnel. This method allows to reliably eliminate upper jaw defect, improve functional and aesthetic results of treatment with minimal injuries caused by operation.Objective is to introduce new way of closure of upper jaw defects.

Molecular genetic background of haemophilia A patients with discrepancy between one-stage and two-stage factor VIII assays

2010 ◽  
Vol 30 (S 01) ◽  
pp. S153-S155
Author(s):  
D. Delev ◽  
S. Pahl ◽  
J. Driesen ◽  
H. Brondke ◽  
J. Oldenburg ◽  
...  
Keyword(s):  
Factor Viii ◽  
Genetic Background ◽  
Molecular Genetic ◽  
Haemophilia A ◽  
Two Stage ◽  
One Stage

Performances of an Artificial Reagent for the One-stage Factor IX Assay

1975 ◽  
Vol 33 (03) ◽  
pp. 547-552 ◽  
Author(s):  
L Meunier ◽  
J. P Allain ◽  
D Frommel
Keyword(s):  
Human Plasma ◽  
Factor Ix ◽  
Severe Haemophilia ◽  
Normal Human Plasma ◽  
Haemophilia B ◽  
One Stage ◽  
Normal Human ◽  
The One

SummaryA mixture of adsorbed normal human plasma and chicken plasma was prepared as reagent for factor IX measurement using a one-stage method. The substrate was found to be specific for factor IX. Its performances tested on samples displaying factor IX activity ranging from <l%–2,500% compared favorably with those obtained when using the plasma of severe haemophilia B patients as substrate.

Sign in / Sign up

Export Citation Format

Share Document